课题基金 / 基金详情

SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS BY NEUROPEPTIDE GENE-TRANSFECT-CELLS

SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE UVEORETINITIS BY NEUROPEPTIDE GENE-TRANSFECT-CELLS
神经肽基因转染细胞抑制实验性自身免疫性葡萄膜视网膜炎
批准号:
17591855
负责人:
KEZUKA Takeshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

KEZUKA Takeshi的其他基金

相似基金

相关文献

中文摘要
翻译
目的:探讨降钙素基因相关肽(CGRP)诱导的成熟树突状细胞(DC)对小鼠实验性自身免疫性葡萄膜视网膜炎(EAU)的抑制作用。C57BL/6小鼠骨髓细胞与GM-CSF共培养6d后,用AutoMACS纯化分化后的CD11~+未成熟DC。未成熟DC进一步与脂多糖(1μg/ml)共同培养过夜,然后与人视黄样受体结合蛋白残基1-20(hIRBP-p)加CGRP或转化生长因子-β2。用弗氏S佐剂中的hIRBP-p和百日咳毒素免疫小鼠,诱导EAU。同时,将hIRBP-p免疫的小鼠静脉注射经CGRP或转化生长因子-β2培养的成熟DC。免疫后第19天检测hIRBP-p特异性迟发型超敏反应。免疫后第21天处死动物,病理评估EAU的程度。注射含有CGRP或转化生长因子-β2和hIRBP-p的成熟DC可显著抑制EAU和抗原特异性的Dh。对照组EAU发生率为87%(13/15只EAU小鼠),TGF-B2培养组EAU发生率为60%(9/15只EAU鼠),CGRP培养组EAU发生率为28%(5/18只EAU鼠)。在接下来的实验中,我们用电穿孔的方法制备了CGRP基因转染树突状细胞。结果表明,CGRP基因转导的DC可抑制IRBP-p的EAU,并抑制其对DHs的增殖。结果表明,成熟DC与CGRP及CGRP基因转导的DC共同培养,对EAU的发生、发展具有免疫抑制作用,且抑制作用强于单独应用转化生长因子-β2的DC。
英文摘要
To investigate the role of the suppression in murine experimental autoimmune uveoretinitis (EAU) by mature dendritic cells (DC) cultured with calcitonin gene-related peptide (CGRP). Bone marrow cells derived from C57BL/6 mice were cultured with GM-CSF for six days, and differentiated CD11^+ immature DC were purified by autoMACS. Immature DC were further cultured with LPS (1 μg/ml) overnight, and then with human interphotoreceptor retinoid binding protein (IRBP) residues 1-20 (hIRBP-p) in the presence of CGRP or TGF-B2. EAU was induced by immunization with hIRBP-p in Freund' s adjuvant and pertussis toxin in mice. At the same time, hIRBP-p-immunized mice were injected the mature DC cultured with CGRP or TGF-B2 intravenously. On day 19 after immunization, hIRBP-p-specific delayed hypersensitivity (DH) were measured. On day 21 after immunization, animals were sacrificed, and assessed the extent of EAU pathologically. EAU and antigen-specific DH was predominantly suppressed by injection of mature DC cultured with CGRP or TGF-B2 and hIRBP-p. Incidence of EAU on control group was 87% (13 of 15 EAU mice), TGF-B2 culture group was 60% (9 of 15 EAU mice), and CGRP culture group was 28% (5 of 18 EAU mice). On the next experiments, we prepared CGRP gene-transfect-DC by electroporation methods. As the results, CGRP gene-transfect-DC can suppress EAU, and suppress DH spepific for IRBP-p. It was demonstrated that mature DC cultured with CGRP and CGRP gene-transfect-DC play an immunosuppressive role in development of EAU, which were more effective than those cultured with TGF-B2.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Possibility of inducing anterior chamber-associated immune deviation by TGF-β2 treatment of monocytes isolated from Behcets patients.
通过 TGF-β2 处理从 Behcets 患者分离的单核细胞诱导前房相关免疫偏差的可能性。
DOI: --
发表时间: 2006
期刊: Exp Eye Res 83
影响因子: --
作者: [Takeuchi M., Keino H., Suzuki J., Usui Y., Hattori T., Takeuchi A., Oh-i K., Okunuki Y., Kezuka T., Usui M.]
通讯作者: Usui M.
Intravitoreal injection of Tacrolimus (FK506) suppresses ongoing experimental autoimmune uveoretinitis in rats.
玻璃体内注射他克莫司 (FK506) 可抑制大鼠正在进行的实验性自身免疫性葡萄膜视网膜炎。
DOI: --
发表时间: 2007
期刊: Br J Ophthalmol 91
影响因子: --
作者: [Oh-i K., Keino H., Goto H., Yamakawa N., Murase K., Usui Y., Kezuka T., Sakai J., Takeuchi M., Usui M.]
通讯作者: Usui M.
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Kezuka T., Atherton SS.(分担執筆)]
通讯作者: Atherton SS.(分担執筆)
DOI: 10.1002/eji.200636138
发表时间: 2006-11
期刊: European Journal of Immunology
影响因子: 5.4
作者: [Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura]
通讯作者: Y. Usui;H. Akiba;M. Takeuchi;T. Kezuka;A. Takeuchi;T. Hattori;Y. Okunuki;Tomohide Yamazaki;H. Yagita;M. Usui;K. Okumura
9
    Suppression of murine experimental autoimmune optic neuritis byinnovation of mature dendritic cells transfected with calcitoningene-related peptide gene
    • 批准号:
      22591967
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2010
    • 负责人:
      KEZUKA Takeshi
    • 依托单位:
    Development of CGRP-gene-transfected immune regulatory cells for treatment of refractory uveoretinitis in human
    • 批准号:
      19592041
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.58万
    • 财政年份:
      2007
    • 负责人:
      KEZUKA Takeshi
    • 依托单位:
    海外基金